世界のてんかん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Epilepsy Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2236 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、てんかん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗てんかん薬、栄養補助食品、迷走神経刺激、外科療法）、用途別市場規模（病院、神経内科センター、在宅ケア施設、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・てんかん治療の市場動向 ・企業の競争状況、市場シェア ・てんかん治療の種類別市場規模（抗てんかん薬、栄養補助食品、迷走神経刺激、外科療法） ・てんかん治療の用途別市場規模（病院、神経内科センター、在宅ケア施設、外来手術センター） ・てんかん治療の北米市場規模2016-2027（アメリカ、カナダ） ・てんかん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・てんかん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・てんかん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・てんかん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Cephalon、Novartis、Pfizer、Johnson & Johnson、GlaxoSmithKline、Sanofi、Sunovion Pharmaceuticals、Bausch Health、Takeda） ・結論

Epilepsy is a chronic neurological disorder that cause recurrent unprovoked seizures, characterized by brief and undetectable episodes of involuntary movement involving either a body part (partial) or the entire body (generalized).
Neurological disorders treatment market is growing at a significant rate, due to increasing prevalence of neurological disorders and technological advancements in the treatment of these conditions.

Market Analysis and Insights: Global Epilepsy Therapeutics Market
The global Epilepsy Therapeutics market size is projected to reach US$ 5065.2 million by 2026, from US$ 4064.1 million in 2019, at a CAGR of 3.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epilepsy Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epilepsy Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epilepsy Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epilepsy Therapeutics market.

Global Epilepsy Therapeutics Scope and Market Size
Epilepsy Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-epileptic Drugs
Dietary Supplements
Vagal Nerve Stimulation
Surgical Therapies

Segment by Application
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Cephalon
Novartis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Sanofi
Sunovion Pharmaceuticals
Bausch Health

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epilepsy Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-epileptic Drugs
1.2.3 Dietary Supplements
1.2.4 Vagal Nerve Stimulation
1.2.5 Surgical Therapies
1.3 Market by Application
1.3.1 Global Epilepsy Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Neurology Centers
1.3.4 Home Care Settings
1.3.5 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epilepsy Therapeutics Market Perspective (2016-2027)
2.2 Epilepsy Therapeutics Growth Trends by Regions
2.2.1 Epilepsy Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epilepsy Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Epilepsy Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Epilepsy Therapeutics Industry Dynamic
2.3.1 Epilepsy Therapeutics Market Trends
2.3.2 Epilepsy Therapeutics Market Drivers
2.3.3 Epilepsy Therapeutics Market Challenges
2.3.4 Epilepsy Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epilepsy Therapeutics Players by Revenue
3.1.1 Global Top Epilepsy Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Epilepsy Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Epilepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epilepsy Therapeutics Revenue
3.4 Global Epilepsy Therapeutics Market Concentration Ratio
3.4.1 Global Epilepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Therapeutics Revenue in 2020
3.5 Epilepsy Therapeutics Key Players Head office and Area Served
3.6 Key Players Epilepsy Therapeutics Product Solution and Service
3.7 Date of Enter into Epilepsy Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epilepsy Therapeutics Breakdown Data by Type
4.1 Global Epilepsy Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Epilepsy Therapeutics Forecasted Market Size by Type (2022-2027)

5 Epilepsy Therapeutics Breakdown Data by Application
5.1 Global Epilepsy Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Epilepsy Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epilepsy Therapeutics Market Size (2016-2027)
6.2 North America Epilepsy Therapeutics Market Size by Type
6.2.1 North America Epilepsy Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Epilepsy Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Epilepsy Therapeutics Market Size by Type (2016-2027)
6.3 North America Epilepsy Therapeutics Market Size by Application
6.3.1 North America Epilepsy Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Epilepsy Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Epilepsy Therapeutics Market Size by Application (2016-2027)
6.4 North America Epilepsy Therapeutics Market Size by Country
6.4.1 North America Epilepsy Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Epilepsy Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Epilepsy Therapeutics Market Size (2016-2027)
7.2 Europe Epilepsy Therapeutics Market Size by Type
7.2.1 Europe Epilepsy Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Epilepsy Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Epilepsy Therapeutics Market Size by Type (2016-2027)
7.3 Europe Epilepsy Therapeutics Market Size by Application
7.3.1 Europe Epilepsy Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Epilepsy Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Epilepsy Therapeutics Market Size by Application (2016-2027)
7.4 Europe Epilepsy Therapeutics Market Size by Country
7.4.1 Europe Epilepsy Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Epilepsy Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epilepsy Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Epilepsy Therapeutics Market Size by Type
8.2.1 Asia-Pacific Epilepsy Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epilepsy Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epilepsy Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Epilepsy Therapeutics Market Size by Application
8.3.1 Asia-Pacific Epilepsy Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epilepsy Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epilepsy Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Epilepsy Therapeutics Market Size by Region
8.4.1 Asia-Pacific Epilepsy Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epilepsy Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epilepsy Therapeutics Market Size (2016-2027)
9.2 Latin America Epilepsy Therapeutics Market Size by Type
9.2.1 Latin America Epilepsy Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Epilepsy Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Epilepsy Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Epilepsy Therapeutics Market Size by Application
9.3.1 Latin America Epilepsy Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Epilepsy Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Epilepsy Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Epilepsy Therapeutics Market Size by Country
9.4.1 Latin America Epilepsy Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Epilepsy Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epilepsy Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Epilepsy Therapeutics Market Size by Type
10.2.1 Middle East & Africa Epilepsy Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epilepsy Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epilepsy Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Epilepsy Therapeutics Market Size by Application
10.3.1 Middle East & Africa Epilepsy Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epilepsy Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epilepsy Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Epilepsy Therapeutics Market Size by Country
10.4.1 Middle East & Africa Epilepsy Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epilepsy Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Epilepsy Therapeutics Introduction
11.1.4 Abbott Laboratories Revenue in Epilepsy Therapeutics Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Cephalon
11.2.1 Cephalon Company Details
11.2.2 Cephalon Business Overview
11.2.3 Cephalon Epilepsy Therapeutics Introduction
11.2.4 Cephalon Revenue in Epilepsy Therapeutics Business (2016-2021)
11.2.5 Cephalon Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Epilepsy Therapeutics Introduction
11.3.4 Novartis Revenue in Epilepsy Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Epilepsy Therapeutics Introduction
11.4.4 Pfizer Revenue in Epilepsy Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Epilepsy Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Epilepsy Therapeutics Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Epilepsy Therapeutics Introduction
11.6.4 GlaxoSmithKline Revenue in Epilepsy Therapeutics Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Epilepsy Therapeutics Introduction
11.7.4 Sanofi Revenue in Epilepsy Therapeutics Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Sunovion Pharmaceuticals
11.8.1 Sunovion Pharmaceuticals Company Details
11.8.2 Sunovion Pharmaceuticals Business Overview
11.8.3 Sunovion Pharmaceuticals Epilepsy Therapeutics Introduction
11.8.4 Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2016-2021)
11.8.5 Sunovion Pharmaceuticals Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Details
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Epilepsy Therapeutics Introduction
11.9.4 Bausch Health Revenue in Epilepsy Therapeutics Business (2016-2021)
11.9.5 Bausch Health Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Epilepsy Therapeutics Introduction
11.10.4 Takeda Revenue in Epilepsy Therapeutics Business (2016-2021)
11.10.5 Takeda Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epilepsy Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-epileptic Drugs
Table 3. Key Players of Dietary Supplements
Table 4. Key Players of Vagal Nerve Stimulation
Table 5. Key Players of Surgical Therapies
Table 6. Global Epilepsy Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Epilepsy Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Epilepsy Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Epilepsy Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Epilepsy Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Epilepsy Therapeutics Market Share by Regions (2022-2027)
Table 12. Epilepsy Therapeutics Market Trends
Table 13. Epilepsy Therapeutics Market Drivers
Table 14. Epilepsy Therapeutics Market Challenges
Table 15. Epilepsy Therapeutics Market Restraints
Table 16. Global Epilepsy Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Epilepsy Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Epilepsy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy Therapeutics as of 2020)
Table 19. Ranking of Global Top Epilepsy Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Epilepsy Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Epilepsy Therapeutics Product Solution and Service
Table 23. Date of Enter into Epilepsy Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Epilepsy Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Epilepsy Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Epilepsy Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Epilepsy Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Epilepsy Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Epilepsy Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Epilepsy Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Epilepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Epilepsy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Epilepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Epilepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Epilepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Epilepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Epilepsy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Epilepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Epilepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Epilepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Epilepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Epilepsy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Epilepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Epilepsy Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Epilepsy Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Epilepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Epilepsy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Epilepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Epilepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Epilepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Epilepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Epilepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Epilepsy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Epilepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Epilepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Epilepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Epilepsy Therapeutics Product
Table 66. Abbott Laboratories Revenue in Epilepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. Cephalon Company Details
Table 69. Cephalon Business Overview
Table 70. Cephalon Epilepsy Therapeutics Product
Table 71. Cephalon Revenue in Epilepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Cephalon Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Epilepsy Therapeutics Product
Table 76. Novartis Revenue in Epilepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Epilepsy Therapeutics Product
Table 81. Pfizer Revenue in Epilepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Epilepsy Therapeutics Product
Table 86. Johnson & Johnson Revenue in Epilepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. GlaxoSmithKline Company Details
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Epilepsy Therapeutics Product
Table 91. GlaxoSmithKline Revenue in Epilepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 92. GlaxoSmithKline Recent Development
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Epilepsy Therapeutics Product
Table 96. Sanofi Revenue in Epilepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Sanofi Recent Development
Table 98. Sunovion Pharmaceuticals Company Details
Table 99. Sunovion Pharmaceuticals Business Overview
Table 100. Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Sunovion Pharmaceuticals Recent Development
Table 102. Bausch Health Company Details
Table 103. Bausch Health Business Overview
Table 104. Bausch Health Epilepsy Therapeutics Product
Table 105. Bausch Health Revenue in Epilepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Bausch Health Recent Development
Table 107. Takeda Company Details
Table 108. Takeda Business Overview
Table 109. Takeda Epilepsy Therapeutics Product
Table 110. Takeda Revenue in Epilepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Takeda Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epilepsy Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Anti-epileptic Drugs Features
Figure 3. Dietary Supplements Features
Figure 4. Vagal Nerve Stimulation Features
Figure 5. Surgical Therapies Features
Figure 6. Global Epilepsy Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Neurology Centers Case Studies
Figure 9. Home Care Settings Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Epilepsy Therapeutics Report Years Considered
Figure 12. Global Epilepsy Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Epilepsy Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Epilepsy Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Epilepsy Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Epilepsy Therapeutics Market Share by Players in 2020
Figure 17. Global Top Epilepsy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Epilepsy Therapeutics Revenue in 2020
Figure 19. Global Epilepsy Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Epilepsy Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Epilepsy Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Epilepsy Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Epilepsy Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Epilepsy Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Epilepsy Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Epilepsy Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Epilepsy Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Epilepsy Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Epilepsy Therapeutics Market Share by Region (2016-2027)
Figure 41. China Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Epilepsy Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Epilepsy Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Epilepsy Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Epilepsy Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Epilepsy Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Epilepsy Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Epilepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Epilepsy Therapeutics Business (2016-2021)
Figure 61. Cephalon Revenue Growth Rate in Epilepsy Therapeutics Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Epilepsy Therapeutics Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Epilepsy Therapeutics Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Epilepsy Therapeutics Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Epilepsy Therapeutics Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Epilepsy Therapeutics Business (2016-2021)
Figure 67. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutics Business (2016-2021)
Figure 68. Bausch Health Revenue Growth Rate in Epilepsy Therapeutics Business (2016-2021)
Figure 69. Takeda Revenue Growth Rate in Epilepsy Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---